PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID
    4.
    发明申请
    PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID 审中-公开
    (+) - 1,4-二氢-7 - [(3S,4S)-3-甲氧基-4-(甲基氨基)-1-吡咯烷基] -4-氧代-1-(2-噻唑烷基) - 1,8-萘啶-3-羧酸

    公开(公告)号:US20100048609A1

    公开(公告)日:2010-02-25

    申请号:US12376118

    申请日:2007-08-01

    申请人: Jeffrey W. Jacobs

    发明人: Jeffrey W. Jacobs

    IPC分类号: A61K31/4375 A61P35/00

    CPC分类号: A61K31/4375

    摘要: Provided herein are light protective pharmaceutical packages for enantiomerically pme (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid. In certain embodiments, the pharmaceutical packages comprise a glass vial containing SNS-595 drug product within a secondary container.

    摘要翻译: 本文提供了对映异构体(+) - 1,4-二氢-7 - [(3S,4S)-3-甲氧基-4-(甲基氨基)-1-吡咯烷基] -4-氧代-1- (2-噻唑基)-1,8-二氮杂萘-3-羧酸。 在某些实施方案中,药物包装包含在次级容器内含有SNS-595药物产品的玻璃小瓶。

    Metal dependent catalytic antibodies and method for producing the same
    9.
    发明授权
    Metal dependent catalytic antibodies and method for producing the same 失效
    金属依赖性催化抗体及其制备方法

    公开(公告)号:US5962291A

    公开(公告)日:1999-10-05

    申请号:US949220

    申请日:1997-10-10

    IPC分类号: C12N9/00 C12N5/12

    CPC分类号: C12N9/0002

    摘要: The present invention relates to catalytic antibodies and a method for producing the same wherein a host is immunized using an "antigen chelate" or more specifically a stable compound capable of chelating metal ions. The immune response mounted in response to the antigen chelate produces antibodies that are capable of binding both a substrate and a metal ion, thus achieving a metal cofactor assisted reaction.

    摘要翻译: 本发明涉及催化抗体及其制备方法,其中使用“抗原螯合物”或更具体地是能够螯合金属离子的稳定化合物免疫宿主。 响应于抗原螯合物而安装的免疫应答产生能够结合底物和金属离子两者的抗体,从而实现金属辅因子辅助反应。